Production of 5-methylbutyrolactone from levulinic acid
Granted 9 Sep 2003 · 2 office actions
Current assignee: EI DuPont De Nemours and Company · originally DuPont
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Leo E. Manzer · Examiner: Joseph K. McKane · AU 1626 · TC 1600
Life of the patent
4 dated eventsAbstract
A process for producing 5-methylbutyrolactone from levulinic acid utilizing an optionally supported metal catalyst is described. The catalyst has both a hydrogenation and a ring-closing function.
Description
6 parts›This application claims benefit of 60/276,581
This application claims benefit of 60/276,581.
›FIELD OF INVENTION
This invention relates to a process for producing 5-methylbutyrolactone from levulinic acid utilizing an optionally supported metal catalyst.
›BACKGROUND
Levulinic acid is a well-known product of hexose acid hydrolysis, and is inexpensively obtained from cellulose feedstocks. Consequently, it is an attractive starting material in producing many useful 5-carbon compounds such as methyltetrahydrofuran and derivatives. 5-methylbutyrolactone, also known as 5-valerolactone or γ-valerolactone, can be produced from levulinic acid as shown below.
U.S. Pat. No. 5,883,266 discloses the use of a bifunctional catalyst having a first function of hydrogenating and a second function of ring opening to prepare a variety of products from levulinic acid including 5-valerolactone. U.S. Pat. No. 2,786,852 disclosed production of 5-valerolactone from levulinic acid using a reduced copper oxide catalyst. U.S. Pat. No. 4,420,622 discloses preparation of 5-alkyl-butyrolactones from levulinic esters using metal catalysts.
›SUMMARY OF THE INVENTION
The present invention is a process of preparing 5-methylbutyrolactone comprising heating levulinic acid in the presence of hydrogen with a catalytic amount of a catalyst having a hydrogenation and a ring-closing function, wherein the catalyst is a metal. The metal catalyst is optionally supported on a catalyst support. Preferably, the catalyst support is selected from the group consisting of carbon, SiO 2 , and Al 2 O 3 . The more preferred catalyst support member is carbon. The most preferred catalyst support member is oxidatively stable carbon.
The metal catalyst of the invention can be selected from the group consisting of Group VII (Groups 8-10) of the Periodic Table of Elements, preferably selected from the group consisting of iridium, palladium, platinum, rhenium, rhodium and ruthenium and combinations thereof. More preferably the metal catalyst is ruthenium; most preferably supported on oxidatively stable carbon.
The process of the instant invention is preferably performed at a temperature from about 100° C. to about 200° C., more preferably at a temperature of about 140-160° C. The process is also preferably performed at a pressure of about 0.5 to about 10.0 MPa, more preferably at a pressure of about 4.0 to about 6.0 MPa. The process is also preferably carried out in a liquid phase.
The catalyst of the instant invention may optionally be promoted with at least one promoter, preferably where the promoter is a metal. Preferably, the promoter is selected from the group consisting of Group VII (Groups 8-10) and Group IB (Group 11) elements of the Periodic Table of Elements, more preferably gold, silver and copper.
›DETAILED DESCRIPTION OF THE INVENTION
The invention is directed to a process for the preparation of 5-methylbutyrolactone, also known as 5-valerolactone or γ-valerolactone, from levulinic acid in the presence of a metal catalyst.
The catalyst of the invention can include one or more metals selected from Group VIII (Group 8-Group 10) elements from the Periodic Table of Elements, more preferably, the group consisting of iridium, palladium, platinum, rhenium, rhodium and ruthenium. The metal catalyst can optionally be supported on a catalyst support. The metal can be deposited on the support using any method known in the art. Preferably, the catalyst has about 1% to about 10% by weight of metal present on the support; more preferably about 5%.
Optionally, the catalyst can include one or more promoters. Preferably the promoter is also a metal, where the promoter is present in less than about 50 weight percent compared to the metal catalyst. More preferably the promoter is a Group VIII or a Group IB (Group 11) metal of the Periodic Table of Elements.
Each catalyst individually has both a hydrogenation and a ring-closing function; that is, the reaction proceeds in one step and produces little or none of the pentyl alcohols such as pentanediol.
The catalyst support can be any solid, inert substance including, but not limited to, metal oxides such as silica, alumina, and titania, and carbons. Preferred are carbons with a surface area greater than 200 m 2 /gm. The catalyst support can be in the form of powder, granules, pellets, or the like.
“Oxidatively stable carbon” is hereby defined as carbon that exhibits substantial weight stability when heated in air. Such carbons are described further in International Publication WO 97/30932. More particularly, when the carbons are heated in air at 125° C. for 30 minutes, followed by heating at 200° C. for 30 minutes, followed by heating at 300° C. for 30 minutes, followed by heating at 350° C. for 45 minutes, followed by heating at 400° C. for 45 minutes, followed by heating at 450° C. for 45 minutes and finally followed by heating at 500° C. for 30 minutes, the carbons employed for the process of this invention lose less than 20% of their weight. This sequence of time and temperature conditions for evaluating the effect of heating carbon samples in air is defined herein as the “WVC Temperature Test”. The WVC Temperature Test may be run using thermal gravimetric analysis (TGA). Carbons which when subjected to the WVC Temperature Test lose about 20% of their weight, or less, are considered to be advantageously oxidatively stable. Carbon from any of the following sources are useful for the process of this invention; wood, peat, coal, coconut shells, bones, lignite, petroleum-based residues and sugar. Commercially available carbons which may be used in this invention include those sold under the following trademarks: Bameby & Sutcliffe™, Darco™, Nuchar™, Columbia JXN™, Columbia LCK™, Calgon PCB™, Calgon BPL™, Westvaco™, Norit™ and Barnaby Cheny NB™.
The process is best performed at from about 50° C. to about 250° C., preferably 100° C. to about 200° C., and more preferably at about 140° C. to about 160° C. The process is performed at a pressure of about 5 to about 100 atmospheres (0.5 MPa to 10 MPa). Preferably the process is performed at a pressure of about 40 to about 60 atmospheres (4.0 to 6.0 MPa). The process is performed in an atmosphere of pure hydrogen gas, or a mixture of hydrogen with inert gases.
The process is preferably carried out in a liquid phase. The choice of solvent is not critical provided the solvent is not detrimental to catalyst, reactant and product. A preferred solvent is dioxane or 5-valerolactone. Preferred reactor designs are trickle bed and slurry.
The following Examples further illustrate the invention.
Materials and Methods
The following abbreviations and definitions are used herein:
Catalyst supports used are listed below. The oxidatively stable carbon catalyst supports were tested for weight stability via thermogravimetric analysis according to the WVC Temperature Test.
›EXAMPLES
The catalysts were prepared by impregnating the catalyst support by incipient wetness with a metal salt. The precursors used were NiCl 2 .6H 2 O (Alfa Aesar, Ward Hill, Mass.), Re 2 O 7 (Alfa), PdCl 2 (Alfa), RuCl 3 .xH 2 O (Aldrich, Milwaukee, Wis.), H 2 PtCl 6 (Johnson Matthey, Ward Hill, Mass.), 5% Rh using RhCl 3 .xH 2 O (Alfa), Re 2 O 7 (Alfa) and IrCl 3 .3H 2 O (Johnson Matthey). The samples were dried and reduced at 400° C. in H 2 for 2 hours. The reaction was performed by placing the feedstock, 1 mL of a 50% solution of levulinic acid in dioxane with the listed amount of catalyst in a 2 ml pressure vessel. The vessel was charged with H 2 to 800 psi (5.5 MPa) for Examples 1-22 and 700 psi (4.8 MPa) for Examples 23-32, and heated to 215° C. for 2 hours. The sample was then cooled and vented and the product analyzed by GC-MS using methoxyethylether as an internal standard. Results are shown in Table 1 below. The column termed “LA Con” refers to LA Conversion, which is measured by subtracting the remaining amount of levulinic acid from the initial amount of levulinic acid (LA initially-LA remaining).
›Tables in the description — 3
| LA | Levulinic acid |
| 5-MGBL | 5-methyl-gamma-butyrolactone |
| Support | Weight loss | Source |
|---|---|---|
| Sibunit carbon | 1.6% | Boreskov Inst. of Catalysis, |
| Novosibirsk, Russia | ||
| Silica grade 55 | n.a. | W. R. Grace & Co., Columbia, MD |
| Calsicat carbon | 14.9% | Englehard Corp., E. Windsor, CT |
| Calgon PCB carbon | 49% | Nalco Chemical Co., Naperville, IL |
| Al 2 O 3 | n.a. | Harshaw Chemical Co., Cleveland, |
| OH |
| H 2 | 5-MGBL | LA | Feedstock | |||
|---|---|---|---|---|---|---|
| Ex. | (psi) | Catalyst | Sel (%) | Con (%) | (mg) | Catalyst (mg) |
| 1 | 700 | 5% Ir / Al 2 O 3 | 70.3 | 36.3 | 974.5 | 103.2 |
| 2 | 700 | 5% Ir / Calgon C | 96.7 | 31.4 | 979.3 | 103.8 |
| 3 | 700 | 5% Ir / Calsicat C | 98.1 | 40.4 | 972.8 | 98 |
| 4 | 800 | 5% Ir / Calsicat C | 98.5 | 98.7 | 986.4 | 100.9 |
| 5 | 800 | 5% Ir / Calsicat C | 95.4 | 99.4 | 990.1 | 101 |
| 6 | 700 | 5% Ir / Sibunit C | 95.1 | 40.8 | 984.8 | 106.1 |
| 7 | 800 | 5% Ir / Sibunit C | 97.0 | 67.3 | 998.2 | 99.8 |
| 8 | 800 | 5% Ir / Sibunit C | 96.9 | 63.5 | 989.9 | 100.7 |
| 9 | 700 | 5% Ir / SiO 2 | 85.7 | 19.9 | 986.3 | 101.7 |
| 10 | 800 | 5% Pd / Calgon C | 89.0 | 15.7 | 967.5 | 99.1 |
| 11 | 800 | 5% Pd / Calsicat C | 92.4 | 32.1 | 982 | 100.4 |
| 12 | 800 | 5% Pd / Calsicat C | 96.8 | 69.4 | 976.6 | 98.6 |
| 13 | 800 | 5% Pd / Calsicat C | 91.5 | 66.8 | 991.8 | 99.7 |
| 14 | 800 | 5% Pd / Sibunit C | 82.2 | 16.3 | 981.3 | 102.3 |
| 15 | 800 | 5% Pd / SiO 2 | 67.0 | 17.7 | 1028.5 | 99 |
| 16 | 800 | 5% Pt / Calgon C | 72.1 | 25.3 | 1017.8 | 105.8 |
| 17 | 700 | 5% Pt / Calsicat C | 82.5 | 15.6 | 940.7 | 99.7 |
| 18 | 800 | 5% Pt / Sibunit C | 81.8 | 18.4 | 958.1 | 97.7 |
| 19 | 800 | 5% Pt / SiO 2 | 71.9 | 19.0 | 981.9 | 97.2 |
| 20 | 700 | 5% Re / Calgon C | 83.2 | 7.8 | 970 | 97.6 |
| 21 | 700 | 5% Re / Calsicat C | 82.3 | 8.9 | 961 | 97.9 |
| 22 | 700 | 5% Re / Sibunit C | 76.4 | 11.1 | 957 | 102.2 |
| 23 | 800 | 5% Rh / Al 2 O 3 | 81.0 | 52.8 | 962.3 | 103.3 |
| 24 | 800 | 5% Rh / Calgon C | 96.1 | 62.1 | 989.9 | 105.2 |
| 25 | 700 | 5% Rh / Calsicat C | 97.6 | 30.7 | 934.8 | 100.4 |
| 26 | 800 | 5% Rh / Calsicat C | 96.0 | 99.9 | 990.6 | 100.9 |
| 27 | 800 | 5% Rh / Calsicat C | 96.1 | 100.0 | 986.1 | 98.3 |
| 28 | 800 | 5% Rh / Sibunit C | 82.1 | 54.8 | 982 | 102.7 |
| 29 | 800 | 5% Rh / Sibunit C | 97.3 | 97.6 | 993 | 102.2 |
| 30 | 800 | 5% Rh / Sibunit C | 97.5 | 96.4 | 990.1 | 100.8 |
| 31 | 800 | 5% Rh / SiO 2 | 83.9 | 43.3 | 993.2 | 97.4 |
| 32 | 800 | 5% Ru / Al 2 O 3 | 64.7 | 42.3 | 999.9 | 96.8 |
| 33 | 800 | 5% Ru / Calgon C | 88.5 | 57.5 | 1010 | 103.2 |
| 34 | 800 | 5% Ru / Calgon C | 73.2 | 32.6 | 974.6 | 10.5 |
| 35 | 800 | 5% Ru / Calgon C | 67.6 | 59.9 | 975.1 | 10.7 |
| 36 | 800 | 5% Ru / Calsicat C | 92.2 | 81.0 | 987.6 | 97.8 |
| 37 | 800 | 5% Ru / Calsicat C | 73.5 | 50.0 | 1002 | 10 |
| 38 | 800 | 5% Ru / Calsicat C | 76.0 | 65.1 | 980.7 | 10.2 |
| 39 | 800 | 5% Ru / Calsicat C | 97.0 | 100.0 | 985.2 | 100.9 |
| 40 | 800 | 5% Ru / Calsicat C | 94.2 | 100.0 | 996.5 | 97.8 |
| 41 | 800 | 5% Ru / Sibunit C | 97.4 | 52.0 | 990.1 | 105.2 |
| 42 | 800 | 5% Ru / Sibunit C | 81.5 | 31.5 | 975.7 | 10.2 |
| 43 | 800 | 5% Ru / Sibunit C | 80.9 | 47.9 | 974.7 | 10.8 |
| 44 | 800 | 5% Ru / Sibunit C | 97.7 | 97.3 | 980.4 | 100 |
| 45 | 800 | 5% Ru / Sibunit C | 98.5 | 98.3 | 988.6 | 100.1 |
| 46 | 800 | 5% Ru / SiO 2 | 81.6 | 37.1 | 1010.9 | 99.3 |
Claims
15 · 1 independent · depth 4Classifications
9 codes- B01J32/00
- B01J23/44
- B01J23/42
- B01J23/36
- B01J23/46
- C07D307/33
- C07B61/00
- C07D315/00
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
2 priority documents›Priority documents — 2
| Type | Document | Date |
|---|---|---|
| provisional | US 60/276581 00 | 16 Mar 2001 |
| related publication | US 20030055270 A1 | 20 Mar 2003 |
Worldwide family
9 members · 8 offices›IP5 & PCT — 7 members
| Office | Publication | Kind | Published | Filed | Status | Title |
|---|---|---|---|---|---|---|
| US | US-2003055270-A1 | A1 | 20 Mar 2003 | 15 Mar 2002 | published | Production of 5-methylbutyrolactone from levulinic acid |
| USthis patent | US-6617464-B2 | B2 | 9 Sep 2003 | 15 Mar 2002 | granted | Production of 5-methylbutyrolactone from levulinic acid |
| EP | EP-1368333-A1 | A1 | 10 Dec 2003 | 14 Mar 2002 | published | Herstellung von 5-methylbutirolakton aus lävulinsäurede |
| JP | JP-2005500987-A | A | 13 Jan 2005 | 14 Mar 2002 | published | レブリン酸からの5−メチルブチロラクトンの製造ja |
| KR | KR-20030082984-A | A | 23 Oct 2003 | 14 Mar 2002 | published | Production of 5-Methylbutyrolactone From Levulinic Acid |
| CN | CN-1498215-A | A | 19 May 2004 | 14 Mar 2002 | published | 由乙酰丙酸制备5-甲基丁内酯的方法zh |
| WO | WO-02074760-A1 | A1 | 26 Sep 2002 | 14 Mar 2002 | published | Production of 5-methylbutyrolactone from levulinic acid |
›Other offices — 2 members
| Office | Publication | Kind | Published | Filed | Status | Title |
|---|---|---|---|---|---|---|
| BR | BR-0208248-A | A | 2 Mar 2004 | 14 Mar 2002 | published | Processo para preparação de 5-metilbutirolactona.pt |
| CA | CA-2437740-A1 | A1 | 26 Sep 2002 | 14 Mar 2002 | published | Production of 5-methylbutyrolactone from levulinic acid |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock